» Articles » PMID: 2437109

Use of a Resin-bound Synthetic Peptide for Identifying a Neutralizing Antigenic Determinant Associated with the Human Immunodeficiency Virus Envelope

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1987 Apr 25
PMID 2437109
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A polyamide-based solid-phase support containing an acid-stable p-(oxymethyl)benzoic acid handle to anchor the COOH-terminal amino acid was utilized in the production of synthetic peptides analogous to amino acid sequences 503-532 from the human immunodeficiency virus (HIV) envelope glycoprotein. The resin-bound peptide was used to induce an antibody response to the native form of glycoprotein 120 in both rabbits and mice. This epitope was detected on the surface of HIV-infected cells and was capable of inducing an in vitro neutralizing HIV antibody response. In addition, sera from some individuals exposed to HIV react with this peptide bound to the resin in a solid-phase immunoassay. These data indicate that we have identified a neutralizing antigenic determinant present on the amino-terminal glycoprotein 120 subunits of HIV by utilizing resin-bound synthetic peptides.

Citing Articles

Viral and Host Factors Regulating HIV-1 Envelope Protein Trafficking and Particle Incorporation.

Anokhin B, Spearman P Viruses. 2022; 14(8).

PMID: 36016351 PMC: 9415270. DOI: 10.3390/v14081729.


Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.

Moore J, Ho D J Virol. 1993; 67(2):863-75.

PMID: 7678308 PMC: 237440. DOI: 10.1128/JVI.67.2.863-875.1993.


Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

Palker T, Clark M, Langlois A, Matthews T, Weinhold K, Randall R Proc Natl Acad Sci U S A. 1988; 85(6):1932-6.

PMID: 2450351 PMC: 279895. DOI: 10.1073/pnas.85.6.1932.


Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees.

Warren R, Wolf H, Shuler K, Eichberg J, Zajac R, Boswell R J Virol. 1990; 64(2):486-92.

PMID: 2404138 PMC: 249135. DOI: 10.1128/JVI.64.2.486-492.1990.


A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization.

Broliden P, Ljunggren K, Hinkula J, Norrby E, Akerblom L, Wahren B J Virol. 1990; 64(2):936-40.

PMID: 2296090 PMC: 249194. DOI: 10.1128/JVI.64.2.936-940.1990.